The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
By convention, peripheral blood stem cell products for autologous transplantation are evaluated for quality by CD34 + cell dose at the time of harvesting. A CD34 + cell dose in excess of 2.0×10 6 /kg of recipient body weight is considered adequate for haematopoietic engraftment. Viable CD34 + cell numbers are enumerated in most laboratories using the ISHAGE single platform...